The global antibacterial drugs market was valued at US$43.55 billion in 2012 and is expected to grow to reach an estimated value of US$45.09 billion by 2019, dominated by generic drugs producers. Following the 'golden age' of antibiotics in the mid-20th century, very few new categories of ...